Q1 2017 Pernix Therapeutics Holdings Inc Earnings Call
Llamada en conferencia Pernix Therapeutics Holdings Inc
Pernix Therapeutics Holdings Inc Conference call or earnings call will be held on 15-may-2017 During the earnings conference call's session Pernix Therapeutics Holdings Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Pernix Therapeutics Holdings Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a specialty pharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs. Our strategy is to continue to create shareholder value by: º Growing sales of the existing products in our portfolio in various ways, including identifying new growth opportunities; º Acquiring additional marketed specialty products or products close to regulatory approval to leverage our existing expertise and infrastructure; and º Pursuing targeted development of a pipeline of post-discovery specialty product candidates. We target underserved segments, such as central nervous system (CNS) indications, including neurology, pain and psychiatry, as well as other specialty therapeutic areas. We promote our core branded products to physicians through our sales force.Leer más Llamada en conferencia